Péter Ferdinandy - Selected Publications#

1. Davidson, S. M., Ferdinandy, P., Andreadou, I., Bøtker, H. E., Heusch, G., Ibáñez, B., … Garcia-Dorado, D. (2019). Multitarget Strategies to Reduce Myocardial Ischemia/Reperfusion Injury. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 73(1), 89–99. http://doi.org/10.1016/j.jacc.2018.09.086]

2. Hausenloy, D., Garcia-Dorado, D., Erik, B. H., Davidson, S., Downey, J., Engel, F., … Ferdinandy, P. (2017). Novel targets and future strategies for acute cardioprotection: Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart. CARDIOVASCULAR RESEARCH, 113(6), 564–585. http://doi.org/10.1093/cvr/cvx049

3. Sluijter, J., Davidson, S., Boulanger, C., Buzas, E., de Kleijn, D., Engel, F., … Ferdinandy, P. (2018). Extracellular vesicles in diagnostics and therapy of the ischaemic heart: Position Paper from the Working Group on Cellular Biology of the Heart of the European Society of Cardiology. CARDIOVASCULAR RESEARCH, 114(1), 19–34. http://doi.org/1[0.1093/cvr/cvx211

4. Fernandez-Aviles, F., Sanz-Ruiz, R., Climent, A., Badimon, L., Bolli, R., Charron, D., … Ferdinandy, P. (2017). Global position paper on cardiovascular regenerative medicine. EUROPEAN HEART JOURNAL, 38(33), 2532–2546. http://doi.org/10.1093/eurheartj/ehx248

5. Perrino, C., Barabasi, A., Condorelli, G., Davidson, S., De Windt, L., Dimmeler, S., … Ferdinandy, P. (2017). Epigenomic and transcriptomic approaches in the post-genomic era: path to novel targets for diagnosis and therapy of the ischemic heart? CARDIOVASCULAR RESEARCH, 113(7), 725–736. http://doi.org/10.1093/cvr/cvx070

6. Davidson, S. M., Andreadou, I., Barile, L., Birnbaum, Y., Cabrera-Fuentes, H. A., Cohen, M. V., … Ferdinandy, P. (2019). Circulating blood cells and extracellular vesicles in acute cardioprotection. CARDIOVASCULAR RESEARCH, 115(7), 1156–1166. http://doi.org/10.1093/cvr/cvy314

7. Andreadou, I., Iliodromitis, E., Lazou, A., Gorbe, A., Giricz, Z., Schulz, R., & Ferdinandy, P. (2017). Effect of hypercholesterolemia on myocardial function, ischemia-reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning. BRITISH JOURNAL OF PHARMACOLOGY, 174(12), 1555–1569. http://doi.org/10.1111/bph.13704

8. Madonna, R., Van Laake, L. W., Botker, H. E., Davidson, S. M., De Caterina, R., Engel, F. B., … Ferdinandy, P & Sluijter, J. P. G. (2019). ESC Working Group on Cellular Biology of the Heart: position paper for Cardiovascular Research: tissue engineering strategies combined with cell therapies for cardiac repair in ischaemic heart disease and heart failure. CARDIOVASCULAR RESEARCH, 115(3), 488–500. http://doi.org/10.1093/cvr/cvz010

9. Ferdinandy, P., Baczko, I., Bencsik, P., Giricz, Z., Gorbe, A., Pacher, P., … Schulz, R. (2019). Definition of hidden drug cardiotoxicity. EUROPEAN HEART JOURNAL, 40(22), 1771–1777. http://doi.org/10.1093/eurheartj/ehy365

10. Baranyai, T., Giricz, Z., Varga, Z., Koncsos, G., Lukovic, D., Makkos, A., … Ferdinandy, P. (2017). In vivo MRI and ex vivo histological assessment of the cardioprotection induced by ischemic preconditioning, postconditioning and remote conditioning in a closed-chest porcine model of reperfused acute myocardial infarction: importance of microvasculature. JOURNAL OF TRANSLATIONAL MEDICINE, 15(1). http://doi.org/10.1186/s12967-017-1166

Google scholar